Yamamoto, I., Rogers, A. H., Reichel, E., Yates, P. A., & Duker, J. S. (2007). Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia. BMJ Group.

Yamamoto, Izumi, Adam H. Rogers, Elias Reichel, Paul A. Yates, ja Jay S. Duker. Intravitreal Bevacizumab (Avastin) As Treatment for Subfoveal Choroidal Neovascularisation Secondary to Pathological Myopia. BMJ Group, 2007.

Yamamoto, Izumi, et al. Intravitreal Bevacizumab (Avastin) As Treatment for Subfoveal Choroidal Neovascularisation Secondary to Pathological Myopia. BMJ Group, 2007.